Pharma-Bio Serv, Inc. (PBSV) income statement
PBSVOTCServices-Management Consulting ServicesFiscal year ends October 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 9/30
$0.48+0.08 (+20.00%)
Close on Oct 19, 2026Market cap $11.00MP/E 48.0Yield –
Pharma-Bio Serv, Inc. income statement
Ratios
Latest available, balances at Jul 31, 2026
Profitability, TTM
- Gross margin
- 32.3%
- Operating margin
- -1.6%
- Net margin
- 2.7%
- Return on equity, FY2025
- -0.8%
Financial strength
- Current ratio
- 11.30
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 152.6%
Valuation
- P/E ratio
- 48.0
- Price to sales
- 1.16
- Price to book
- 1.05
- Dividend yield
- –
See a number that looks wrong?